ATE459376T1 - Pharmazeutische formulierung und darin enthaltende liganden; uea-1 mimetika - Google Patents
Pharmazeutische formulierung und darin enthaltende liganden; uea-1 mimetikaInfo
- Publication number
- ATE459376T1 ATE459376T1 AT02761028T AT02761028T ATE459376T1 AT E459376 T1 ATE459376 T1 AT E459376T1 AT 02761028 T AT02761028 T AT 02761028T AT 02761028 T AT02761028 T AT 02761028T AT E459376 T1 ATE459376 T1 AT E459376T1
- Authority
- AT
- Austria
- Prior art keywords
- uea
- mimetics
- pharmaceutical formulation
- ligands contained
- ligands
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000003446 ligand Substances 0.000 title 1
- 230000008685 targeting Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30282201P | 2001-07-02 | 2001-07-02 | |
| US30286801P | 2001-07-03 | 2001-07-03 | |
| PCT/US2002/020948 WO2003004062A1 (en) | 2001-07-02 | 2002-07-02 | Pharmaceutical formulations and ligands for use therein; mimetics for uea-1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE459376T1 true ATE459376T1 (de) | 2010-03-15 |
Family
ID=26973111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02761028T ATE459376T1 (de) | 2001-07-02 | 2002-07-02 | Pharmazeutische formulierung und darin enthaltende liganden; uea-1 mimetika |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7166296B2 (enExample) |
| EP (1) | EP1404372B1 (enExample) |
| JP (1) | JP2004536109A (enExample) |
| AT (1) | ATE459376T1 (enExample) |
| CA (1) | CA2452257A1 (enExample) |
| DE (1) | DE60235549D1 (enExample) |
| WO (1) | WO2003004062A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| WO2007052641A1 (ja) * | 2005-11-01 | 2007-05-10 | Kumamoto University | 腸管免疫賦活剤 |
| KR101138312B1 (ko) | 2009-04-13 | 2012-04-27 | 주식회사 바이오에프디엔씨 | 펩타이드 유도체 및 그를 포함하는 화장료 조성물 |
| WO2012156376A1 (en) | 2011-05-13 | 2012-11-22 | Merrion Pharmaceuticals Ireland Ltd. | Use of plant lectins to target leukocytes |
-
2002
- 2002-07-02 CA CA002452257A patent/CA2452257A1/en not_active Abandoned
- 2002-07-02 JP JP2003510071A patent/JP2004536109A/ja active Pending
- 2002-07-02 US US10/187,550 patent/US7166296B2/en not_active Expired - Fee Related
- 2002-07-02 DE DE60235549T patent/DE60235549D1/de not_active Expired - Fee Related
- 2002-07-02 AT AT02761028T patent/ATE459376T1/de not_active IP Right Cessation
- 2002-07-02 EP EP02761028A patent/EP1404372B1/en not_active Expired - Lifetime
- 2002-07-02 WO PCT/US2002/020948 patent/WO2003004062A1/en not_active Ceased
-
2006
- 2006-06-20 US US11/425,237 patent/US20060276628A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1404372A1 (en) | 2004-04-07 |
| US20060276628A1 (en) | 2006-12-07 |
| JP2004536109A (ja) | 2004-12-02 |
| US7166296B2 (en) | 2007-01-23 |
| WO2003004062A9 (en) | 2003-04-10 |
| DE60235549D1 (de) | 2010-04-15 |
| US20040062796A1 (en) | 2004-04-01 |
| WO2003004062A1 (en) | 2003-01-16 |
| EP1404372B1 (en) | 2010-03-03 |
| CA2452257A1 (en) | 2003-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108532T1 (el) | Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων | |
| BR0308090A (pt) | conjugados de agentes citotóxicos ou terapêuticos e peptìdios biologicamente ativos | |
| GEP20063741B (en) | Nonaryl-Heterocyclic NMDA/NR2B Antagonists | |
| MXPA05002814A (es) | Formulacion para agentes lipofilicos. | |
| NO20062504L (no) | Sammensetninger og doseringsformer for forbedret absorpsjon | |
| WO2003096990A3 (en) | Protein cages for the delivery of medical imaging and therapy | |
| ATE355065T1 (de) | Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika | |
| PL360262A1 (pl) | Kompozycje polimerycznych micelli | |
| DE60038183D1 (de) | Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe | |
| SE0301700D0 (sv) | Novel compounds | |
| MXPA02010801A (es) | Agentes diagnosticos, de representacion y terapeuticos cationicos asociados con sitios vasculares activados. | |
| AR034213A1 (es) | Composiciones de medicamentos sobre la base de agentes anticolinergicos e inhibidores de pde-iv | |
| TR200100054T2 (tr) | Paroksetin metansülfonat | |
| MXPA03007857A (es) | Compuestos y composiciones para entregar agentes activos. | |
| DE60209929D1 (de) | Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen | |
| EA200602047A1 (ru) | Сульфонилэтилфосфородиамидаты, предназначенные для применения при лечении рака | |
| BRPI0406858A (pt) | Liberação controlada de agentes altamente solúveis | |
| ATE549353T1 (de) | Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen | |
| WO2006089114A3 (en) | Methods and compositions for treating an anthrax toxin mediated condition | |
| ITRM20030363A1 (it) | Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse. | |
| EP1379508A4 (en) | N- (ARYL) -2-ARYLETHESULFONAMIDES AND THEIR THERAPEUTIC APPLICATIONS | |
| EP1491210A4 (en) | THERAPEUTIC MEDICAMENT USING ANTIBODY PRESENTING HOLES PROTEIN NANOTEHICLES AND HIGH PROTEIN NANOTEHICLES | |
| ATE459376T1 (de) | Pharmazeutische formulierung und darin enthaltende liganden; uea-1 mimetika | |
| PL368686A1 (en) | Novel aminobenzoephenones | |
| HRP20080597T3 (en) | Cancer combination therapy comprising azd2171 and zd1839 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |